Clinical Trial Update: The SPECTRUM Study: An Observational Study to Learn More About How Well Aflibercept 8 mg Works in Treating Visual Impairment Due to Neovascular Age-related Macular Degeneration or Diabetic Macula Edema

View source ↗

Summary

This is an observational study sponsored by Bayer evaluating how well aflibercept 8 mg works for visual impairment due to neovascular age-related macular degene…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Neovascular Age-related Macular Degeneration

Drugs mentioned

• Aflibercept (Aflibercept)

Snippet

Sponsor: Bayer | Conditions: Visual Impairment, Neovascular Age-related Macular Degeneration (nAMD) | Status: ACTIVE_NOT_RECRUITING